Search
for
Sort by
Research 511–540 of 1000+
- Sex differences in the hypothalamic–pituitary–adrenal axis’ response to stress: an important role for gonadal hormones
- Androgen biosynthetic pathways in the human prostate
- Telogen effluvium
- Human hair follicle organ culture: theory, application and perspectives
- Oxidative stress in ageing of hair
- Histopathology of non-scarring alopecia
- Impact of estrogens in males and androgens in females
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- 9 Role of 5α-reductase in health and disease
- Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp
- Biology and Genetics of Hair
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Cell Types Promoting Goosebumps Form a Niche to Regulate Hair Follicle Stem Cells
- The Use of Platelet-Rich Plasma in Aesthetic and Regenerative Medicine: A Comprehensive Review
- The hair growth promoting effect of Sophora flavescens extract and its molecular regulation
- The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study
- Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth
- Mechanical forces in skin disorders
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- The control of hair growth: An overview
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Sex Steroid Hormone Receptors in Human Skin Appendage and its Neoplasms
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk
- Modulating hair follicle size with <i>Wnt10b/DKK1</i> during hair regeneration
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*